Demonstrations continued across the country as states adjusted to a decision that upended nearly 50 years of constitutional protection for abortion rights.
Some 13 U.S. states have 'trigger laws' to immediately ban abortion in the wake of Roe's reversal.
MILAN, June 26, 2022--Italfarmaco Group announced today positive topline data from its completed Phase 3 EPIDYS trial with Givinostat, the company’s proprietary histone deacetylase (HDAC) inhibitor, in boys with Duchenne Muscular Dystrophy (DMD). The primary objective of the study was to evaluate the effects of Givinostat on slowing disease progression in ambulant DMD boys aged 6 years and above on chronic steroids. The study compared Givinostat to placebo and met the primary endpoint (change fr
Símbolo | Último precio | Cambio | Cambio de % |
---|---|---|---|
Símbolo | Último precio | Cambio | Cambio de % |
---|---|---|---|
Símbolo | Último precio | Cambio | Cambio de % |
---|---|---|---|
Símbolo | Último precio | Cambio | Cambio de % |
---|---|---|---|
Símbolo | Último precio | Cambio | Cambio de % |
---|---|---|---|
Símbolo | Último precio | Cambio | Cambio de % |
---|---|---|---|
Símbolo | Último precio | Cambio | Cambio de % |
---|---|---|---|
Símbolo | Último precio | Cambio | Cambio de % |
---|---|---|---|